Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials.

52W Range

3rdpctl

Volume

0.20×avg

Market Cap

20.32MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Neuphoria Therapeutics Inc.

NEUPNASDAQ Global Market·USD·Closed

Neuphoria Therapeutics Inc.

NEUPNASDAQ·USD·Closed

$3.76

−0.27%

$3.76

−$0.01 (0.27%)

52W Range

3rdpctl

Volume

0.20×avg

Mkt Cap

20.32MUSD

P/E

-0.3TTM

Div Yield

–ann

NEUP: Neuphoria Therapeutics Inc. Stock Analysis | finqOS